Skip to content

Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection

Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01816269
Acronym
Scaling and Hp
Enrollment
300
Registered
2013-03-22
Start date
2013-03-31
Completion date
2013-05-31
Last updated
2013-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Pylori Infection

Keywords

Helicobacter pylori, Dental scaling, Eradication, Reinfection, Helicobacter status

Brief summary

Patients who had received H.pylori eradication treatment will be categorised as eradication and reinfection status and whether dental scaling has any influence on these results.

Detailed description

Patients over 18 years with no comorbidities especially liver, cardiac and haemorrhagic diathesis and giving informed consent will be categorised according to their status of dental scaling, eradication and reinfection rates of h.pylori. Statistical examination will include the multiple regression and Chi-Square. The result will emphasize the influence of dental scaling on eradication (Presence of Hp cure 1-6 months after treatment) and reinfection ( reappearance of Hp 12 months later than the treatment).

Interventions

None listed

Sponsors

Goztepe Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients over 18 with h.pylori positivity and received anti-Hp treatment giving informed consent to analyse of their data on this subject.

Exclusion criteria

* Comorbidities with cardiac, liver and medical contraindication to perform dental scaling.

Design outcomes

Primary

MeasureTime frame
The eradication and reinfection rates in dental scaled and non-scaled patients.last 1 year

Secondary

MeasureTime frame
Reinfection rate of patients treated for H.pylori1 year

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026